O'Byrne P M, Jones G L
Am Rev Respir Dis. 1986 Jul;134(1):69-72. doi: 10.1164/arrd.1986.134.1.69.
Exercise causes bronchoconstriction in asthmatic subjects, which is usually followed by a refractory period during which exercise of the same intensity will cause less bronchoconstriction. This study examined the role of contractile prostaglandins in the initial bronchoconstriction after exercise and the role of inhibitory prostaglandins in the refractoriness after exercise. Subjects were pretreated with indomethacin, 50 mg twice daily, on 1 occasion or placebo on 2 occasions for 3 days. This was followed by 2 exercise challenges on a bicycle ergometer at least 30 min apart. Indomethacin did not alter the initial bronchoconstriction after exercise. The maximal fall in FEV1 after the first exercise challenge after placebo was 0.67 +/- 0.17 L and 0.68 +/- 0.17 L, and after indomethacin it was 0.67 +/- 0.12 L. Indomethacin, however, did prevent refractoriness after exercise. The maximal fall in FEV1 after the second exercise challenge after placebo was 0.31 +/- 0.06 L and 0.36 +/- 0.12 L, and after indomethacin it was 0.64 +/- 0.12 L. These results indicate that indomethacin pretreatment does not alter bronchoconstriction after exercise, and they also indicate that indomethacin pretreatment prevents refractoriness after exercise in asthmatic subjects.
运动可导致哮喘患者支气管收缩,随后通常会出现一个不应期,在此期间相同强度的运动引起的支气管收缩会减轻。本研究探讨了收缩性前列腺素在运动后初始支气管收缩中的作用以及抑制性前列腺素在运动后不应期中的作用。受试者在1个疗程中每日两次服用50毫克吲哚美辛,共3天,或在2个疗程中服用安慰剂。之后在自行车测力计上进行2次运动激发试验,每次间隔至少30分钟。吲哚美辛并未改变运动后初始支气管收缩情况。服用安慰剂后第一次运动激发试验后FEV1的最大下降值为0.67±0.17升和0.68±0.17升,服用吲哚美辛后为0.67±0.12升。然而,吲哚美辛确实可预防运动后的不应期。服用安慰剂后第二次运动激发试验后FEV1的最大下降值为0.31±0.06升和0.36±0.12升,服用吲哚美辛后为0.64±0.12升。这些结果表明,吲哚美辛预处理不会改变运动后的支气管收缩,同时也表明吲哚美辛预处理可预防哮喘患者运动后的不应期。